Shaffer James P 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 26, 2019
Insider Transaction Report
Form 4
Shaffer James P
Chief Business Officer
Transactions
- Award
Common Stock
2017-09-05$9.90/sh+1,500$14,854→ 8,421 total - Award
Common Stock
2019-03-05$7.95/sh+1,500$11,921→ 12,921 total - Award
Common Stock
2017-03-06$8.20/sh+1,301$10,671→ 6,921 total - Award
Common Stock
2018-03-05$8.03/sh+1,500$12,049→ 9,921 total - Award
Common Stock
2018-09-05$7.95/sh+1,500$11,921→ 11,421 total - Award
Stock Option ( Right to Buy)
2019-03-21+50,000→ 50,000 totalExercise: $14.31Exp: 2029-03-20→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Includes shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The option vests in equal monthly installments over 48 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date.